A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma
PHASE1
This study will evaluate the safety, tolerability, pharmacokinetics, and ac...
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma
PHASE1
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
PHASE1
This study will evaluate the safety, tolerability, pharmacokinetics, and ac...